CD47 and obesity due to melanocortin 4 receptor deficiency: Together, data from this study revealed a novel role for CD47 in regulation of energy homeostasis and the development of obesity, suggesting that CD47 may serve as a potential therapeutic target to combat obesity and metabolic complications.